Últimos Artículos de Lancet Diabetes & Endocrinology
- [Correspondence] Chronic hepatitis, osteoporosis, and men: under-recognised and underdiagnosed
- [In Focus] Alex Brown: fighting for the health of Indigenous Australians
- [Correspondence] Positioning newer drugs in the management of type 2 diabetes
- [Editorial] Insulin at 100: time for action on costs
- [Correspondence] Positioning newer drugs in the management of type 2 diabetes
- [Comment] Avoiding a legacy of unequal non-communicable disease burden after the COVID-19 pandemic
- [Articles] Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records
- [Comment] Cancer overtakes vascular disease as leading cause of excess death associated with diabetes
- [In Focus] Action framework on healthy food: a way forward for the public sector
- [Articles] Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study
- [Comment] Adverse pregnancy outcomes in women with type 1 or type 2 diabetes
- [Review] Management of diabetes and hyperglycaemia in the hospital
- [Comment] Menopause transition: a golden age to prevent cardiovascular disease
- [Articles] Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study
- [Comment] Thyroid cancer incidence in children and adolescents
- [Correspondence] COVID-19 vaccine prioritisation for type 1 and type 2 diabetes
- [Comment] Vitamin D and respiratory infections
- [Articles] The effect of vitamin D supplementation on acute respiratory tract infection in older Australian adults: an analysis of data from the D-Health Trial
- [Editorial] Vitamin D and COVID-19: why the controversy?
- [Comment] Public health emergency or opportunity to profit? The two faces of the COVID-19 pandemic